AptarGroup (ATR) Raised to “Buy” at Zacks Investment Research
AptarGroup (NYSE:ATR) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday. The brokerage presently has a $94.00 target price on the industrial products company’s stock. Zacks Investment Research‘s price target would suggest a potential upside of 11.19% from the stock’s current price.
According to Zacks, “AptarGroup is well poised for growth given its focus on innovation, solid product pipeline and demand in the Pharma market. The company has implemented a commercial excellence program to boost sales and marketing capability in Beauty + Home segment, which will lead to improved results. Estimates have been stable lately ahead of the company’s Q4 earnings release. The company has positive record of earnings surprises in recent quarters. Moreover, the stock outperformed the industry in the past year.”
Several other research analysts also recently commented on the company. KeyCorp reaffirmed a “hold” rating on shares of AptarGroup in a report on Friday, October 27th. Robert W. Baird reaffirmed a “hold” rating and set a $85.00 target price on shares of AptarGroup in a report on Thursday, October 12th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. AptarGroup presently has a consensus rating of “Hold” and an average price target of $83.71.
In other news, Director Stephen J. Hagge sold 25,000 shares of the business’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $86.12, for a total value of $2,153,000.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Robert Kuhn sold 5,000 shares of the business’s stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $87.43, for a total value of $437,150.00. The disclosure for this sale can be found here. Insiders sold a total of 56,000 shares of company stock worth $4,852,930 over the last three months. 5.30% of the stock is owned by company insiders.
Large investors have recently made changes to their positions in the company. Zions Bancorporation acquired a new position in shares of AptarGroup in the 3rd quarter valued at about $187,000. Susquehanna International Group LLP lifted its stake in shares of AptarGroup by 233.1% in the 2nd quarter. Susquehanna International Group LLP now owns 2,528 shares of the industrial products company’s stock valued at $220,000 after purchasing an additional 4,428 shares during the period. Vident Investment Advisory LLC acquired a new position in shares of AptarGroup in the 3rd quarter valued at about $221,000. Centiva Capital LP acquired a new position in shares of AptarGroup in the 4th quarter valued at about $235,000. Finally, Coldstream Capital Management Inc. increased its position in AptarGroup by 1.1% in the 2nd quarter. Coldstream Capital Management Inc. now owns 2,805 shares of the industrial products company’s stock valued at $244,000 after buying an additional 30 shares in the last quarter. 91.40% of the stock is currently owned by institutional investors.
AptarGroup, Inc is a provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, homecare, prescription drug, consumer healthcare, injectables, food and beverage markets. The Company has manufacturing facilities located throughout the world, including North America, Europe, Asia and South America.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.